Allergan, NY End Antitrust Fight Over Dementia Drug
Allergan and New York state have settled an antitrust suit that accused the drugmaker of steering patients away from one of its dementia drugs and toward another to avoid competition with...To view the full article, register now.
Already a subscriber? Click here to view full article